ERα-mediated regulation of oncogenic TMPRSS2-ERG fusion and oestrogen regulation of the EBAG9 gene, which confirms aggressive behaviour of prostate cancer, are noted examples that suggest a functional ERα-signalling pathway exists in prostate cancer. The gene discussed is ERG; the disease is prostate carcinoma.